# PsiQuantum and AMD Expand Quantum Computing Partnership

PsiQuantum and AMD are expanding their collaboration on classical computing infrastructure and applications for fault-tolerant quantum systems, with pharmaceutical research and drug discovery as the initial commercial focus. The collaboration has no reported contract solicitation or partnership value and is not itself a government award. For contractors, it signals potential demand for quantum hardware, accelerated computing, software, and scientific applications, alongside federal funding activity that includes DOE quantum programs and CHIPS and Science Act incentives.

- DOE’s Q Competition offers up to **$215 million** in awards, including a **$100 million** pool for systems with at least 100 logical qubits. The competition opened in September; no closing date is provided in the signals.
- Other reported funding signals include more than **$2 billion** in CHIPS and Science Act quantum incentives, with PsiQuantum among the selected companies, and **$159 million** in DOE Genesis Mission Phase II awards. These amounts describe separate programs, not the value of the PsiQuantum–AMD collaboration.
- Companies providing quantum hardware, classical high-performance computing, software, and scientific research applications can assess whether their capabilities align with these federal program areas and the partnership’s pharmaceutical research focus.

**Jurisdictions:** federal
**Industries:** Information Technology
**Topics:** Grants & Funding, Digital Infrastructure
**Published:** November 13, 2026

### Government Entities
- U.S. Department of Energy (DOE)
- U.S. Department of Commerce (Commerce)
- Brookhaven National Laboratory (BNL)
- Oak Ridge National Laboratory (ORNL)
- State of Illinois

### Vendors
- PsiQuantum (awardee)
- AMD ()

### Sources
- [PsiQuantum, AMD Expand Hybrid Quantum Computing Partnership](https://www.executivebiz.com/articles/psiquantum-amd-hybrid-quantum-classical-computing-partnership) - ExecutiveBiz